Canagliflozin, approved 10 years ago, has the most available data among SGLT2 inhibitors and was studied alone and with metformin.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.